VeraDermics Insider Buy: Childs Buys 294k Shares at $17 for Phase 3 Hair‑Loss Trial
VeraDermics insider buying: John Childs buys 294 k shares at $17 amid Phase‑3 trial hype—signals confidence, potential upside, and market insight.
3 minutes to read
VeraDermics Inc